采纳股份：全资子公司采纳医疗近日获得三项实用新型专利证书

Core Viewpoint - Company announced the receipt of three utility model patent certificates from the National Intellectual Property Administration, which are related to its main business products [2] Group 1: Patent Acquisition - The patents include "a pressure-resistant anti-reflux infusion pipeline," "pressure display syringe," and "fixed measurement syringe," all of which are independently developed by the company [2] - The patents will take effect from the date of the authorization announcement and are expected to enhance the company's intellectual property protection system [2] Group 2: Impact on Business - The acquisition and application of these patents are not expected to have a significant impact on the company's short-term operating performance [2] - However, the patents will contribute to the establishment of a continuous innovation mechanism, helping the company maintain its technological leadership and enhance its core competitiveness [2]